279 related articles for article (PubMed ID: 21784285)
1. Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia.
Rungruangsiripan M; Sitthimongkol Y; Maneesriwongul W; Talley S; Vorapongsathorn T
Arch Psychiatr Nurs; 2011 Aug; 25(4):269-83. PubMed ID: 21784285
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
3. Risk profiles for non-adherence to antipsychotic medications.
McCann TV; Boardman G; Clark E; Lu S
J Psychiatr Ment Health Nurs; 2008 Oct; 15(8):622-9. PubMed ID: 18803735
[TBL] [Abstract][Full Text] [Related]
4. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
McCann TV; Clark E; Lu S
J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
[TBL] [Abstract][Full Text] [Related]
5. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with antipsychotic medication adherence in community-based patients with schizophrenia in Hong Kong: a cross sectional study.
Bressington D; Mui J; Gray R
Int J Ment Health Nurs; 2013 Feb; 22(1):35-46. PubMed ID: 22738372
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence and significant others' support of consumers with schizophrenia in Australia.
McCann TV; Lu S
Nurs Health Sci; 2009 Sep; 11(3):228-34. PubMed ID: 19689630
[TBL] [Abstract][Full Text] [Related]
8. Predicting intentions and adherence behavior in the context of organ transplantation: gender differences of provided social support.
Scholz U; Klaghofer R; Dux R; Roellin M; Boehler A; Muellhaupt B; Noll G; Wüthrich RP; Goetzmann L
J Psychosom Res; 2012 Mar; 72(3):214-9. PubMed ID: 22325701
[TBL] [Abstract][Full Text] [Related]
9. [Drug compliance and health locus of control in schizophrenia].
Combes C; Feral F
Encephale; 2011 May; 37 Suppl 1():S11-8. PubMed ID: 21600328
[TBL] [Abstract][Full Text] [Related]
10. Compliance and schizophrenia: the predictive potential of insight into illness, symptoms, and side effects.
Kao YC; Liu YP
Compr Psychiatry; 2010; 51(6):557-65. PubMed ID: 20965300
[TBL] [Abstract][Full Text] [Related]
11. Treatment adherence in schizophrenia and schizoaffective disorder.
Goff DC; Hill M; Freudenreich O
J Clin Psychiatry; 2011 Apr; 72(4):e13. PubMed ID: 21527119
[TBL] [Abstract][Full Text] [Related]
12. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
[TBL] [Abstract][Full Text] [Related]
13. Medication adherence and subjective weight perception in patients with first-episode psychotic disorder.
Wong MM; Chen EY; Lui SS; Tso S
Clin Schizophr Relat Psychoses; 2011 Oct; 5(3):135-41. PubMed ID: 21983497
[TBL] [Abstract][Full Text] [Related]
14. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
Chang YT; Tao SG; Lu CL
Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
[TBL] [Abstract][Full Text] [Related]
15. Novelty seeking and medication adherence in patients with schizophrenia.
Aukst Margetić B; Jakovljević M; Ivanec D; Tošić G; Margetić B
Psychiatry Res; 2011 Mar; 186(1):141-3. PubMed ID: 20630601
[TBL] [Abstract][Full Text] [Related]
16. Control beliefs, therapeutic relationship, and adherence in schizophrenia outpatients: a cross-sectional study.
Jaeger S; Weißhaupt S; Flammer E; Steinert T
Am J Health Behav; 2014 Nov; 38(6):914-23. PubMed ID: 25207516
[TBL] [Abstract][Full Text] [Related]
17. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with medication non-adherence in patients suffering from schizophrenia: a cross-sectional study in a universal coverage health-care system.
Dassa D; Boyer L; Benoit M; Bourcet S; Raymondet P; Bottai T
Aust N Z J Psychiatry; 2010 Oct; 44(10):921-8. PubMed ID: 20932206
[TBL] [Abstract][Full Text] [Related]
19. The 4-Point ordinal Alliance Self-report: a self-report questionnaire for assessing therapeutic relationships in routine mental health.
Misdrahi D; Verdoux H; Lançon C; Bayle F
Compr Psychiatry; 2009; 50(2):181-5. PubMed ID: 19216896
[TBL] [Abstract][Full Text] [Related]
20. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
